Partners

National Infectious Diseases Day is comprised of the following members and supporters:

Canadian Foundation for Infectious Diseases (CFID)

The Canadian Foundation for Infectious Diseases (CFID) was established in 1989 to fund critical research and help protect Canadians and people worldwide from infectious diseases. CFID is the fundraising arm of the Association of Medical Microbiology and Infectious Disease (AMMI) Canada -- our country’s largest association of microbiologists and infectious disease specialists. CFID pledges to use every dollar raised responsibly and productively to support research, education and professional development of Canada’s infectious disease experts. For more information, please visit www.researchid.com.

 

Community and Hospital Infection Control Association - Canada (CHICA - Canada)

CHICA-Canada is a national, multi-disciplinary, voluntary association of Infection Prevention and Control Professionals (IPCPs) with 20 chapters across the country dedicated to the health of Canadians by promoting excellence in the practice of infection prevention and control. For more information, please visit www.chica.org.

Astellas Canada

Astellas Pharma Canada, Inc. is highly focused on customers and their needs and is committed to making a difference in the treatment of infectious diseases. Astellas Pharma Canada is dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. It is one of the Astellas Group of companies in North America and an affiliate of Astellas Pharma Inc., located in Tokyo. The organization is committed to becoming a global pharmaceutical leader by combining outstanding R&D and marketing capabilities. Additional corporate information is available at www.astellas.com/ca.

BD Diagnostics

BD, a leading global medical technology company that makes and sells medical devices, instrumented systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs more than 25,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.

Baxter

For more information on Baxter, go to www.baxter.com.